The integration of specific probiotic strains with selective prebiotics, a concept known as synbiotics, represents a sophisticated approach in the development of Live Biotherapeutic Products (LBPs) and functional fermented foods. Recent research into Enterococcus hirae F42, a strain derived from infant intestines, highlights the critical role of oligosaccharides in modulating fermentation kinetics and product quality.1 This study provides a technical blueprint for the selection of synergistic ingredients to enhance metabolic output. Creative Biolabs, a leader in LBP solutions, leverages this scientific framework to offer end-to-end CRO services, including strain isolation, metabolic profiling, and fermentation optimization. By bridging the gap between raw laboratory data and commercial-grade bioprocesses, we empower researchers to accelerate their synbiotic pipelines. Inquire About Our LBP Development Services
Overview: Synergy of Enterococcus hirae F42 and Oligosaccharides in Fermentation1
The research titled "Effects of oligosaccharides in synergy with Enterococcus hirae F42 derived from infant intestines on the milk fermentation process and quality" systematically evaluates the functional interaction between a specific probiotic candidate and various prebiotics. The study aimed to investigate the synergistic effects of four types of oligosaccharides, fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), isomalto-oligosaccharides (IMO), and xylo-oligosaccharides (XOS), on the fermentation performance of Enterococcus hirae F42. This strain, isolated from the infant gut, was assessed for its potential to improve the sensory and nutritional profile of fermented milk.
Experimental Methodology:
-
Strain Selection: E. hirae F42 was isolated and identified using molecular sequencing.
-
Fermentation Conditions: Reconstituted skim milk was used as the base medium, supplemented with different concentrations of oligosaccharides.
-
Kinetic Monitoring: Parameters such as pH decrease, titratable acidity, and viable cell counts were measured at regular intervals.
-
Quality Assessment: The study employed Gas Chromatography-Ion Mobility Spectrometry (GC-IMS) to analyze volatile organic compounds (VOCs), alongside texture profile analysis (TPA) and rheological measurements.
The study concluded that the combination of E. hirae F42 with specific oligosaccharides modulates the physical, sensory, and functional characteristics of the fermented matrix, presenting a viable candidate framework for next-generation synbiotic development.
Mapping Advanced Experimental Paths to Professional CRO Services
Based on the experimental workflow described in the literature, Creative Biolabs has identified key technical requirements and matched them with our specialized CRO services to support your LBP or probiotic research.
Microbial Isolation, Identification, and Characterization
To replicate or expand upon the isolation of infant-derived strains like E. hirae F42, we offer:
-
Strain Isolation & Purification: Targeted isolation from complex biological samples (feces, milk, tissues).
-
Genomic Identification: Full-length 16S rRNA sequencing and Whole Genome Sequencing (WGS) for precise taxonomic classification and safety assessment (e.g., absence of antibiotic resistance genes).
-
Phenotypic Profiling: Testing for acid/bile tolerance, adhesion capabilities, and antimicrobial activity.
Synbiotic Synergy Screening & Optimization
The selection of the right prebiotic (FOS vs. GOS vs. XOS) is critical. Our platform provides:
-
High-Throughput Prebiotic Utilization Assays: Rapidly screening microbial growth across hundreds of carbohydrate sources.
-
In Vitro Co-culture Models: Simulating the synergistic interactions between probiotics and prebiotics in controlled environments.
-
Metabolic Flux Analysis: Quantifying how specific prebiotics alter the production of Short-Chain Fatty Acids (SCFAs) or other metabolites.
Moving from lab-scale to pilot-scale requires precise control, as seen in the milk fermentation study:
-
Media Optimization: Customizing fermentation media to maximize biomass and metabolic yield.
-
Process Parameter Control: Real-time monitoring of pH, dissolved oxygen, and temperature using automated bioreactors.
-
Scale-up Services: Transitioning protocols from 1L to 50L+ fermentation volumes while maintaining strain stability.
Comprehensive Metabolomics and Analytical Testing
To quantify the "quality" of fermentation as the literature suggests:
-
Volatile Compound Analysis: Utilizing GC-MS or LC-MS to profile flavor and aroma compounds.
-
Texture and Rheology Analysis: Evaluating the physical properties of fermented matrices.
-
Stability Testing: Long-term viability studies of LBPs under various storage conditions.
Scientific Product Portfolio for Synbiotic Research
To streamline your internal laboratory validation and assay development, Creative Biolabs provides a highly specialized selection of off-the-shelf commercial products designed to align with the material needs of advanced probiotic research:
-
Reference Strains and Microbial Samples: We maintain an extensive inventory of fully characterized probiotic strains, including standard control strains (Lactobacillus reuteri, Lactobacillus bulgaricus) and specific Enterococcus species, available for comparative benchmarking and functional screening.
-
High-Purity Oligosaccharides and Prebiotics: To facilitate synergy testing, we offer commercial-grade and analytical-grade prebiotic reference standards, including Chitooligosaccharides (COS), Fructooligosaccharides (FOS), and Xylooligosaccharides (XOS).
Why Choose Creative Biolabs as Your Lead CRO Partner
Navigating the complexities of Live Biotherapeutic Product (LBP) and synbiotic development demands a partner with robust infrastructure and stringent quality control. Creative Biolabs distinguishes itself through several core operational pillars:
State-of-the-Art Analytical Instrumentation
Our facilities house advanced high-resolution mass spectrometers (LC-MS/MS, GC-MS), automated multi-bioreactor fermentation suites, and specialized anaerobic chambers, ensuring precision data generation.
Bioinformatics and Computational Biology Expertise
Beyond raw data generation, our dedicated bioinformatics team translates complex multi-omics datasets into biological insights, delivering publication-ready heatmaps, PCA plots, pathway enrichment analyses, and differential metabolite identification.
Tailored Project Execution
We recognize that no two strains or prebiotic formulations are identical. Our scientific team collaborates directly with your R&D department to design bespoke study protocols that adapt to your specific timeline, regulatory goals, and budget constraints.
Broader Application Fields of Synbiotic Research
The integration of functional strains like E. hirae with synergistic oligosaccharides extends far beyond conventional dairy manufacturing. The services and products provided by Creative Biolabs support client innovations across diverse fields:
-
Next-Generation Probiotic Supplements: Formulating targeted synbiotic capsules and powders aimed at metabolic homeostasis, immune modulation, and gut barrier reinforcement.
-
Live Biotherapeutic Products (LBPs): Developing regulated pharmaceutical-grade live biotherapeutics targeting specific clinical indications such as Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), and gut dysbiosis.
-
Functional Food and Infant Nutrition: Designing specialized infant formulas and bioactive dairy products that mimic natural human milk oligosaccharide (HMO) dynamics and early-stage microbiota colonization.
The intricate metabolic interplay between infant-derived Enterococcus hirae F42 and distinct prebiotics highlights the necessity of multi-omics approaches in modern biotherapeutic validation. Successfully commercializing these findings requires translating raw scientific methodologies into repeatable, robust developmental pipelines. Creative Biolabs provides the necessary analytical infrastructure, specialized microbial product lines, and advanced bioinformatics platforms to convert raw strains into optimized synbiotic assets.
Are you looking to evaluate a novel strain or optimize a synbiotic formulation? Contact our scientific team today to schedule a technical consultation or request a detailed project quotation.
Frequently Asked Questions (FAQs)
How does Creative Biolabs ensure the safety profile of Enterococcus species or other novel strains intended for probiotic use?
We perform complete whole-genome sequencing (WGS) using hybrid long-read and short-read technologies to screen for the presence of mobile genetic elements, antibiotic resistance genes (ARGs), and virulence factors (such as hemolysin or gelatinase genes). This is paired with phenotypic assays to ensure full regulatory alignment.
How do you determine the optimal ratio of prebiotic to probiotic?
We utilize Response Surface Methodology (RSM) and high-throughput screening to statistically determine the concentrations that yield the highest synergistic effect on growth and metabolic output.
Do you offer custom strain isolation services from specific donor populations?
Absolutely. We can manage the entire process of isolation from specific cohorts (e.g., infants, elderly, or specific disease states) under strict ethical and technical guidelines.
Reference
-
Albadwi, Fatima et al. "Effects of oligosaccharides in synergy with Enterococcus hirae F42 derived from infant intestines on the milk fermentation process and quality." Journal of dairy science 109,6 (2026): 6007-6023. doi:10.3168/jds.2025-27853. Distributed under Open Access license CC BY 4.0, without modification.
